• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Major Adverse Cardiovascular Events After 12 Months Among Patients With Acute Coronary Syndrome Receiving Loading Doses of Atorvastatin Prior to Planned PCI.

作者信息

Lopes Renato D, de Barros E Silva Pedro G M, Damiani Lucas Petri, Santos Renato Hideo Nakagawa, Alexander John H, Granger Christopher B, Berwanger Otavio

机构信息

Duke Clinical Research Institute, Durham, North Carolina.

Brazilian Clinical Research Institute, São Paulo, Brazil.

出版信息

JAMA. 2020 Feb 25;323(8):787-789. doi: 10.1001/jama.2020.0118.

DOI:10.1001/jama.2020.0118
PMID:32096839
Abstract
摘要

相似文献

1
Major Adverse Cardiovascular Events After 12 Months Among Patients With Acute Coronary Syndrome Receiving Loading Doses of Atorvastatin Prior to Planned PCI.在计划进行经皮冠状动脉介入治疗（PCI）之前接受负荷剂量阿托伐他汀治疗的急性冠状动脉综合征患者中，12个月后的主要不良心血管事件
JAMA. 2020 Feb 25;323(8):787-789. doi: 10.1001/jama.2020.0118.
2
Effect of Loading Dose of Atorvastatin Prior to Planned Percutaneous Coronary Intervention on Major Adverse Cardiovascular Events in Acute Coronary Syndrome: The SECURE-PCI Randomized Clinical Trial.计划进行经皮冠状动脉介入治疗前给予阿托伐他汀负荷剂量对急性冠状动脉综合征主要不良心血管事件的影响：SECURE-PCI随机临床试验
JAMA. 2018 Apr 3;319(13):1331-1340. doi: 10.1001/jama.2018.2444.
3
Effect of loading dose of atorvastatin therapy prior to percutaneous coronary intervention in patients with acute coronary syndrome: a meta-analysis of six randomized controlled trials.急性冠状动脉综合征患者经皮冠状动脉介入治疗前阿托伐他汀负荷剂量治疗的效果：六项随机对照试验的荟萃分析
Drug Des Devel Ther. 2019 Apr 16;13:1233-1240. doi: 10.2147/DDDT.S196588. eCollection 2019.
4
Timing of Loading Dose of Atorvastatin in Patients Undergoing Percutaneous Coronary Intervention for Acute Coronary Syndromes: Insights From the SECURE-PCI Randomized Clinical Trial.急性冠状动脉综合征患者行经皮冠状动脉介入治疗时阿托伐他汀负荷剂量的时机：来自 SECURE-PCI 随机临床试验的见解。
JAMA Cardiol. 2018 Nov 1;3(11):1113-1118. doi: 10.1001/jamacardio.2018.3408.
5
Effect of high-dose rosuvastatin loading before percutaneous coronary intervention in Chinese patients with acute coronary syndrome: A systematic review and meta-analysis.大剂量瑞舒伐他汀负荷量在接受经皮冠状动脉介入治疗的中国急性冠脉综合征患者中的作用：一项系统评价和荟萃分析。
PLoS One. 2017 Feb 23;12(2):e0171682. doi: 10.1371/journal.pone.0171682. eCollection 2017.
6
High Loading Dose of Atorvastatin for the Prevention of Serum Creatinine and Cystatin C-Based Contrast-Induced Nephropathy Following Percutaneous Coronary Intervention.高负荷剂量阿托伐他汀预防经皮冠状动脉介入治疗后基于血清肌酐和胱抑素C的造影剂诱导的肾病
Angiology. 2018 Sep;69(8):692-699. doi: 10.1177/0003319717750903. Epub 2018 Jan 17.
7
The effects and mechanisms of high loading dose rosuvastatin therapy before percutaneous coronary intervention in patients with acute coronary syndrome.急性冠状动脉综合征患者经皮冠状动脉介入治疗前高负荷剂量瑞舒伐他汀治疗的效果及机制
Int J Cardiol. 2013 Sep 1;167(5):2350-3. doi: 10.1016/j.ijcard.2012.11.032. Epub 2012 Nov 26.
8
Efficacy of High-Intensity Atorvastatin for Asian Patients Undergoing Percutaneous Coronary Intervention.高强度阿托伐他汀对接受经皮冠状动脉介入治疗的亚洲患者的疗效。
Ann Pharmacother. 2016 Sep;50(9):725-33. doi: 10.1177/1060028016654722. Epub 2016 Jun 15.
9
Effect of intensive statin therapy on clinical outcomes among patients undergoing percutaneous coronary intervention for acute coronary syndrome. PCI-PROVE IT: A PROVE IT-TIMI 22 (Pravastatin or Atorvastatin Evaluation and Infection Therapy-Thrombolysis In Myocardial Infarction 22) Substudy.强化他汀类药物治疗对急性冠脉综合征经皮冠状动脉介入治疗患者临床结局的影响。PCI-PROVE IT：PROVE IT-TIMI 22（普伐他汀或阿托伐他汀评估和感染治疗-心肌梗死 22）亚研究。
J Am Coll Cardiol. 2009 Dec 8;54(24):2290-5. doi: 10.1016/j.jacc.2009.09.010.
10
Efficacy and Safety of Loading-Dose Rosuvastatin Therapy in Elderly Patients with Acute Coronary Syndromes Undergoing Elective Percutaneous Coronary Intervention.负荷剂量瑞舒伐他汀治疗老年急性冠状动脉综合征患者择期经皮冠状动脉介入治疗的疗效与安全性
Clin Drug Investig. 2015 Dec;35(12):777-84. doi: 10.1007/s40261-015-0335-1.

引用本文的文献

1
Association between BNT162b2 or CoronaVac COVID-19 vaccines and major adverse cardiovascular events among individuals with cardiovascular disease.BNT162b2 或 CoronaVac 新冠疫苗与心血管疾病患者主要不良心血管事件的相关性。
Cardiovasc Res. 2022 Jul 27;118(10):2329-2338. doi: 10.1093/cvr/cvac068.
2
Expression and Clinical Prognostic Value of Platelet in Acute Coronary Syndrome.血小板在急性冠状动脉综合征中的表达及临床预后价值
Int J Gen Med. 2020 Oct 9;13:791-802. doi: 10.2147/IJGM.S275481. eCollection 2020.